Duality Advisers’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,844
| Closed | -$2.11M | – | 674 |
|
|
2023
Q1 | $2.11M | Buy |
+20,844
| New | +$2.11M | 0.24% | 155 |
|
|
2022
Q2 | – | Sell |
-7,729
| Closed | -$725K | – | 770 |
|
|
2022
Q1 | $725K | Sell |
7,729
-3,319
| -30% | -$311K | 0.08% | 403 |
|
|
2021
Q4 | $941K | Buy |
+11,048
| New | +$941K | 0.1% | 308 |
|
|
2021
Q2 | – | Sell |
-3,372
| Closed | -$328K | – | 673 |
|
|
2021
Q1 | $328K | Sell |
3,372
-7,920
| -70% | -$770K | 0.03% | 485 |
|
|
2020
Q4 | $1.08M | Sell |
11,292
-5,368
| -32% | -$514K | 0.08% | 326 |
|
|
2020
Q3 | $1.6M | Buy |
+16,660
| New | +$1.6M | 0.1% | 271 |
|